Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 7 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2021 Filed Feb 17, 2021 22:13 UTC |
Ralhan SameerSVP, CFO
|
Tax withholdingCommon Stock | 224 | $26.14 | $5,855.36 |
DisclosureSEC source: 0001627223-21-000005 · primary_doc.xml · nonDerivative · entry 2 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,119.8489 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. F3 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:13 UTC |
Ralhan SameerSVP, CFO
|
GrantCommon Stock | 597 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-21-000005 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,343.8489 F1 · shares: Vesting of performance share units (PSUs) F3 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 16:31 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,101.2505 | $24.79 | $27,300.00 |
DisclosureSEC source: 0001627223-21-000001 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,023.9156 Underlying: Common Stock · 1,101.2505 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 20:24 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 605.0827 | $24.79 | $15,000.00 |
DisclosureSEC source: 0001627223-21-000002 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,046.4332 Underlying: Common Stock · 605.0827 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. F4 · balance_after: This total has been adjusted to reflect the correct number of derivative securities beneficially owned due to a clerical error that overreported the total derivative securities in previous filings. With respect to the Form 4 filing on 04-30-2020, Table II, Box 9 should have been 6475.5096. With respect to the Form 4 filing on 07-02-2020, Table II, Box 9 should have been 7558.0357. With respect to the Form 4 filing on 10-02-2020, Table II, Box 9 should have been 8364.1052. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 12:39 UTC |
Vergnano MarkDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 153,392 | $0.00 Strike: $15.49 | $0.00 |
DisclosureSEC source: 0001627223-20-000047 · primary_doc.xml · derivative · entry 4 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 153,392 shares Expires 2021-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 was effected pursuant to a previously reported Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options were issued to the reporting person while he was employed by DuPont and were converted to Chemours options in connection with the Company's separation from DuPont. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 12:39 UTC |
Vergnano MarkDirector · President and CEO
|
SaleCommon Stock | 153,392 | $27.28 | $4,184,963.26 |
DisclosureSEC source: 0001627223-20-000047 · primary_doc.xml · nonDerivative · entry 2 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,353 F2 · kind: Price reported is an average. Shares were sold in multiple transactions at prices ranging from $26.79 to $27.87. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 12:39 UTC |
Vergnano MarkDirector · President and CEO
|
Exercise / conversionCommon Stock | 153,392 | $15.49 | $2,375,597.24 |
DisclosureSEC source: 0001627223-20-000047 · primary_doc.xml · nonDerivative · entry 1 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 was effected pursuant to a previously reported Rule 10b5-1 trading plan. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 13:47 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
GrantCommon Stock | 39,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000046 · primary_doc.xml · nonDerivative · entry 1 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,438.903 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on December 1, 2023. F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 12:31 UTC |
Kelliher Susan M.SVP, People & Health Services
|
GrantCommon Stock | 19,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000044 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,625.301 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on December 1, 2023. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 17:46 UTC |
Ralhan SameerSVP, CFO
|
GrantCommon Stock | 39,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000045 · primary_doc.xml · nonDerivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,647 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on December 1, 2023. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:03 UTC |
Snell E BryanPresident, Titanium Tech
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,341 | $0.00 Strike: $15.49 | $0.00 |
DisclosureSEC source: 0001627223-20-000043 · primary_doc.xml · derivative · entry 3 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,341 shares Expires 2021-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were issued to the reporting person while he was employed by DuPont and were converted to Chemours options in connection with the Company's separation from DuPont. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:03 UTC |
Snell E BryanPresident, Titanium Tech
|
SaleCommon Stock | 28,341 | $22.29 | $631,720.89 |
DisclosureSEC source: 0001627223-20-000043 · primary_doc.xml · nonDerivative · entry 2 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,891 F1 · price: Shares were sold in multiple transactions at prices ranging from $22.20 to $22.41. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:03 UTC |
Snell E BryanPresident, Titanium Tech
|
Exercise / conversionCommon Stock | 28,341 | $15.49 | $439,002.09 |
DisclosureSEC source: 0001627223-20-000043 · primary_doc.xml · nonDerivative · entry 1 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 13:17 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,305.5954 | $20.91 | $27,300.00 |
DisclosureSEC source: 0001627223-20-000040 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,566.4915 Underlying: Common Stock · 1,305.5954 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 16:51 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 717.3601 | $20.91 | $15,000.00 |
DisclosureSEC source: 0001627223-20-000041 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,306.5555 Underlying: Common Stock · 717.3601 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:58 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,728 | $0.00 Strike: $15.49 | $0.00 |
DisclosureSEC source: 0001627223-20-000039 · primary_doc.xml · derivative · entry 3 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,728 shares Expires 2021-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were issued to the reporting person while he was employed by DuPont and were converted to Chemours options in connection with the Company's separation from DuPont. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:58 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
SaleCommon Stock | 2,728 | $20.56 | $56,087.68 |
DisclosureSEC source: 0001627223-20-000039 · primary_doc.xml · nonDerivative · entry 2 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,940 Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:58 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
Exercise / conversionCommon Stock | 2,728 | $15.49 | $42,256.72 |
DisclosureSEC source: 0001627223-20-000039 · primary_doc.xml · nonDerivative · entry 1 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 09:23 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,778.5016 | $15.35 | $27,300.00 |
DisclosureSEC source: 0001627223-20-000037 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,991.2329 Underlying: Common Stock · 1,778.5016 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:28 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 977.1987 | $15.35 | $15,000.00 |
DisclosureSEC source: 0001627223-20-000038 · primary_doc.xml · derivative · entry 3 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,589.1954 Underlying: Common Stock · 977.1987 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable in installments upon separation from service. F3 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:44 UTC |
Kelliher Susan M.SVP, People & Health Services
|
Tax withholdingCommon Stock | 289 | $13.57 | $3,921.73 |
DisclosureSEC source: 0001627223-20-000036 · primary_doc.xml · nonDerivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,872 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| May 07, 2020 Filed May 8, 2020 21:57 UTC |
Newman MarkSenior VP & COO
|
PurchaseCommon Stock | 1,000 | $11.62 | $11,620.00 |
DisclosureSEC source: 0001627223-20-000035 · primary_doc.xml · nonDerivative · entry 2 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,344 Read SEC document |
| May 07, 2020 Filed May 8, 2020 21:57 UTC |
Newman MarkSenior VP & COO
|
PurchaseCommon Stock | 1,500 | $11.62 | $17,428.35 |
DisclosureSEC source: 0001627223-20-000035 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,344 Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 21:01 UTC |
CRAWFORD CURTIS JDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000031 · primary_doc.xml · nonDerivative · entry 1 CRAWFORD CURTIS J · CIK 0001014318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,312 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed May 1, 2020 00:21 UTC |
ANASTASIO CURTDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000028 · primary_doc.xml · nonDerivative · entry 1 ANASTASIO CURT · CIK 0001032097 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,659 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed May 1, 2020 00:46 UTC |
CRANSTON MARY BDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000030 · primary_doc.xml · nonDerivative · entry 1 CRANSTON MARY B · CIK 0001104268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,740 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 20:11 UTC |
BROWN RICHARD HDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000027 · primary_doc.xml · nonDerivative · entry 1 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,282 F1 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed May 1, 2020 01:26 UTC |
Kane Erin NDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000033 · primary_doc.xml · nonDerivative · entry 1 Kane Erin N · CIK 0001684077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,859 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed May 1, 2020 01:44 UTC |
Keohane Sean DDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000034 · primary_doc.xml · nonDerivative · entry 1 Keohane Sean D · CIK 0001435737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,209 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed Apr 30, 2020 20:37 UTC |
BELL BRADLEY JDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000029 · primary_doc.xml · nonDerivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,906 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| April 28, 2020 Filed May 1, 2020 01:15 UTC |
Farrell Dawn LDirector
|
GrantCommon Stock | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000032 · primary_doc.xml · nonDerivative · entry 1 Farrell Dawn L · CIK 0001645639 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,906 F1 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:29 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 3,078 | $8.87 | $27,301.86 |
DisclosureSEC source: 0001627223-20-000025 · primary_doc.xml · derivative · entry 1 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,889 Underlying: Common Stock · 3,078 shares Expires not disclosed F1 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · derivative.exercise_date: Payable upon separation from service. F2 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:51 UTC |
BELL BRADLEY JDirector
|
GrantStock Units · Derivative | 1,691 | $8.87 | $14,999.17 |
DisclosureSEC source: 0001627223-20-000026 · primary_doc.xml · derivative · entry 1 BELL BRADLEY J · CIK 0001190859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348 Underlying: Common Stock · 1,691 shares Expires not disclosed F1 · derivative.exercise_price: Units are credited under the Chemours compensation plan for directors and convert one-for-one to Chemours common stock. F2 · derivative.exercise_date: Payable in installments upon separation from service. F2 · derivative.expiration_date: Payable in installments upon separation from service. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 15:00 UTC |
Snell E BryanPresident, Titanium Tech
|
PurchaseCommon Stock | 11,000 | $10.15 | $111,650.00 |
DisclosureSEC source: 0001627223-20-000024 · primary_doc.xml · nonDerivative · entry 1 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,891 Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 19:45 UTC |
BROWN RICHARD HDirector
|
PurchaseCommon Stock | 7,500 | $14.06 | $105,450.00 |
DisclosureSEC source: 0001627223-20-000014 · primary_doc.xml · nonDerivative · entry 1 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,586 F1 · price: Price reported is a weighted average. Shares were purchased in multiple transactions at prices ranging from $13.74 to $14.37. F2 · balance_after: Includes directly owned shares, stock units and dividend equivalent units. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:34 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
GrantStock Option (Right to Buy) · Derivative | 85,561 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000016 · primary_doc.xml · derivative · entry 2 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,561 Underlying: Common Stock · 85,561 shares Expires 2030-03-02 F2 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 20:34 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
GrantCommon Stock | 34,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000016 · primary_doc.xml · nonDerivative · entry 1 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,940 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on March 2, 2023. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:18 UTC |
Shelton David CSVP, GC & Corp. Secretary
|
GrantStock Option (Right to Buy) · Derivative | 101,604 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000021 · primary_doc.xml · derivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,604 Underlying: Common Stock · 101,604 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:00 UTC |
Snell E BryanPresident, Titanium Tech
|
GrantStock Option (Right to Buy) · Derivative | 96,256 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000019 · primary_doc.xml · derivative · entry 1 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,256 Underlying: Common Stock · 96,256 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:37 UTC |
Vergnano MarkDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 598,930 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000023 · primary_doc.xml · derivative · entry 1 VERGNANO MARK P · CIK 0001474107 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,930 Underlying: Common Stock · 598,930 shares Expires 2030-03-02 F1 · derivative.exercise_date: he options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:28 UTC |
Newman MarkSenior VP & COO
|
GrantStock Option (Right to Buy) · Derivative | 160,427 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000022 · primary_doc.xml · derivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,427 Underlying: Common Stock · 160,427 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:08 UTC |
Kelliher Susan M.SVP, People & Health Services
|
GrantStock Option (Right to Buy) · Derivative | 74,866 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000020 · primary_doc.xml · derivative · entry 1 Kelliher Susan M. · CIK 0001568507 · SVP, People & Health Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,866 Underlying: Common Stock · 74,866 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:51 UTC |
Ralhan SameerSVP, CFO & Treasurer
|
GrantStock Option (Right to Buy) · Derivative | 106,951 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000018 · primary_doc.xml · derivative · entry 1 Ralhan Sameer · CIK 0001778813 · SVP, CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,951 Underlying: Common Stock · 106,951 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:44 UTC |
Parker ErichSVP Corp Communications & CBO
|
GrantStock Option (Right to Buy) · Derivative | 37,433 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000017 · primary_doc.xml · derivative · entry 1 Parker Erich · CIK 0001645203 · SVP Corp Communications & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,433 Underlying: Common Stock · 37,433 shares Expires 2030-03-02 F1 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:22 UTC |
Abbott Matthew SVP, CAO & Controller
|
GrantStock Option (Right to Buy) · Derivative | 26,737 | $0.00 Strike: $14.43 | $0.00 |
DisclosureSEC source: 0001627223-20-000015 · primary_doc.xml · derivative · entry 2 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,737 Underlying: Common Stock · 26,737 shares Expires 2030-03-02 F2 · derivative.exercise_date: The options are scheduled to vest in three equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 01:22 UTC |
Abbott Matthew SVP, CAO & Controller
|
GrantCommon Stock | 17,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000015 · primary_doc.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,843 F1 · shares: Restricted stock unit (RSU) award scheduled to vest on March 2, 2023. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:51 UTC |
Sparks Edwin CPresident, Fluoro & Chem Sol
|
Tax withholdingCommon Stock | 255 | $14.86 | $3,789.30 |
DisclosureSEC source: 0001627223-20-000013 · primary_doc.xml · nonDerivative · entry 1 Sparks Edwin C · CIK 0001735771 · President, Fluoro & Chem Sol 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,290 F1 · kind: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 02:31 UTC |
Abbott Matthew SVP, CAO & Controller
|
Tax withholdingCommon Stock | 857 | $14.86 | $12,735.02 |
DisclosureSEC source: 0001627223-20-000012 · primary_doc.xml · nonDerivative · entry 1 Abbott Matthew S · CIK 0001786056 · VP, CAO & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518 F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:52 UTC |
Snell E BryanPresident, Titanium Tech
|
Tax withholdingCommon Stock | 6,562 | $19.37 | $127,105.94 |
DisclosureSEC source: 0001627223-20-000008 · primary_doc.xml · nonDerivative · entry 2 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,891 F2 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:52 UTC |
Snell E BryanPresident, Titanium Tech
|
GrantCommon Stock | 19,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-20-000008 · primary_doc.xml · nonDerivative · entry 1 Snell E Bryan · CIK 0001645180 · President, Titanium Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,453 F1 · shares: Vesting of performance share units (PSUs). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.